Search research articles
Contact Us
Filters
Showing results (121-130 of 154) with videos related to
Page
of 16
Sort By:
International Journal of Dermatology
|
July 25, 2024
Real-world effectiveness and drug survival of guselkumab over a period of 3 years in moderate-to-severe plaque psoriasis, including difficult-to-treat areas
Natalia Rompoti, Theognosia Vergou, Irene Stefanaki, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 20, 2024
Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasis
Natalia Rompoti, Irene Stefanaki, Pantelis Panagakis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 30, 2015
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline
Alexander Stratigos, Claus Garbe, Celeste Lebbe, et al.
Dermatology and Therapy
|
April 10, 2024
Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study
Michela Starace, Francesca Pampaloni, Elisabeth Lazaridou, et al.
The Journal of Investigative Dermatology
|
November 18, 2011
Clinical expression and new SPINK5 splicing defects in Netherton syndrome: unmasking a frequent founder synonymous mutation and unconventional intronic mutations
Matthieu Lacroix, Laetitia Lacaze-Buzy, Laetitia Furio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 16, 2026
Drug survival of bimekizumab, guselkumab, and risankizumab after secondary IL-17 inhibitor failure
Irene Stefanaki, Ioannis-Alexios Koumprentziotis, Charitomeni Vavouli, et al.
Clinical and Experimental Dermatology
|
November 8, 2025
Long-term effectiveness, safety and prognostic factors of response to treatment with bimekizumab in psoriasis patients: results from a real-world multicentre study
Alexander Katoulis, Evangelia Papadavid, Ioannis-Alexios Koumprentziotis, et al.
Journal of Clinical Medicine
|
February 24, 2024
Use of Dermoscopy among Greek Dermatologists in Everyday Clinical Practice: A National Questionnaire-Based Study
Dimitrios Sgouros, Eleni Routsi, Athina Evangelodimou, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 24, 2025
Pregnancy-associated melanoma epidemiology: A multicentre European study
Maria Kostaki, Michaela Plaka, Vasiliki Chardalia, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 20, 2026
Pregnancy-associated melanoma: A distinct entity requiring vigilance
Maria Kostaki, Michaela Plaka, Vasiliki Chardalia, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 154) with videos related to
Sort By:
Page
of 16
International Journal of Dermatology
|
July 25, 2024
Real-world effectiveness and drug survival of guselkumab over a period of 3 years in moderate-to-severe plaque psoriasis, including difficult-to-treat areas
Natalia Rompoti, Theognosia Vergou, Irene Stefanaki, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 20, 2024
Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasis
Natalia Rompoti, Irene Stefanaki, Pantelis Panagakis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 30, 2015
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline
Alexander Stratigos, Claus Garbe, Celeste Lebbe, et al.
Dermatology and Therapy
|
April 10, 2024
Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study
Michela Starace, Francesca Pampaloni, Elisabeth Lazaridou, et al.
The Journal of Investigative Dermatology
|
November 18, 2011
Clinical expression and new SPINK5 splicing defects in Netherton syndrome: unmasking a frequent founder synonymous mutation and unconventional intronic mutations
Matthieu Lacroix, Laetitia Lacaze-Buzy, Laetitia Furio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 16, 2026
Drug survival of bimekizumab, guselkumab, and risankizumab after secondary IL-17 inhibitor failure
Irene Stefanaki, Ioannis-Alexios Koumprentziotis, Charitomeni Vavouli, et al.
Clinical and Experimental Dermatology
|
November 8, 2025
Long-term effectiveness, safety and prognostic factors of response to treatment with bimekizumab in psoriasis patients: results from a real-world multicentre study
Alexander Katoulis, Evangelia Papadavid, Ioannis-Alexios Koumprentziotis, et al.
Journal of Clinical Medicine
|
February 24, 2024
Use of Dermoscopy among Greek Dermatologists in Everyday Clinical Practice: A National Questionnaire-Based Study
Dimitrios Sgouros, Eleni Routsi, Athina Evangelodimou, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 24, 2025
Pregnancy-associated melanoma epidemiology: A multicentre European study
Maria Kostaki, Michaela Plaka, Vasiliki Chardalia, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 20, 2026
Pregnancy-associated melanoma: A distinct entity requiring vigilance
Maria Kostaki, Michaela Plaka, Vasiliki Chardalia, et al.
Page
of 16